Previous 10 | Next 10 |
STOUGHTON, Mass., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced the pricing of its offering of $125,000,000 aggregate principal amount of 2.625% convertible senior notes due 2026 (the “notes”) in a public offering registered un...
Shares of Collegium Pharmaceutical (NASDAQ: COLL) were sinking 13.6% as of 3:24 p.m. EST on Monday. The decline came after the drugmaker announced a $125 million proposed offering of senior convertible notes. The bad news with Collegium's proposed offering is that it means that dilutio...
Collegium Pharmaceutical ( COLL ) is a name that I covered with great interest in the past, as I generally liked the positioning of the firm. It has been nearly a year since I last updated the thesis as I saw some comforting developments at the time. The company has seen a few breakthrough...
Gainers: vTv Therapeutics (NASDAQ: VTVT ) +57% . More news on: vTv Therapeutics Inc., Taubman Centers, Inc., NanoViricides, Inc., Stocks on the move, , Read more ...
Collegium Pharmaceutical ( COLL -10.4% ) is down in early trade in response to its $125M public offering of convertible senior notes due 2026. More news on: Collegium Pharmaceutical, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Myomo (NYSEMKT: MYO ) -19% . More news on: Myomo, Inc., Arbutus Biopharma Corporation, Biohaven Pharmaceutical Holding Company Ltd., Stocks on the move, , Read more ...
Shares of Collegium Pharmaceutical (NASDAQ: COLL) jumped more than 20% today after the company announced an agreement to purchase the U.S. rights to the Nucynta franchise from Assertio Therapeutics for $375 million. The opioid franchise includes Nucynta extended-release and immediate-release...
Gainers: Benitec Biopharma (NASDAQ: BNTC ) +51% . More news on: Benitec Biopharma Limited, Assertio Therapeutics, Inc., Ocwen Financial Corporation, Stocks on the move, , Read more ...
Assertio Therapeutics (NASDAQ: ASRT ) +63% on buying Nucynta U.S. rights from Assertio in $375M deal. More news on: Assertio Therapeutics, Inc., Yield10 Bioscience, Inc., Telenav, Inc., Stocks on the move, Read more ...
Collegium Pharmaceutical (NASDAQ: COLL ) +8.3% after-hours on news it agrees to acquire the U.S. rights to the Nucynta franchise from Assertio Therapeutics (NASDAQ: ASRT ) for $375M; ASRT +56.7% . More news on: Collegium Pharmaceutical, Inc., Assertio Therapeutics, Inc., Healthcare st...
News, Short Squeeze, Breakout and More Instantly...
Collegium Pharmaceutical Inc. Company Name:
COLL Stock Symbol:
NASDAQ Market:
Collegium Pharmaceutical Inc. Website:
2024-07-20 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-10 14:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...